Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Survey Reveals Majority of Americans Hold onto Myths About What Causes Colds and How to Treat Them

Nine Out of 10 Pharmacists Agree Patients Harbor Misconceptions about Managing Colds


News provided by

Matrixx Initiatives, Inc.

Oct 19, 2010, 08:00 ET

Share this article

Share toX

Share this article

Share toX

SCOTTSDALE, Ariz., Oct. 19 /PRNewswire/ -- A new national survey of U.S. adults has found the majority of Americans are misinformed about what causes the common cold, and how and when they should treat it.  Much of this confusion comes from myths Americans grew up with that have stuck with them throughout their adult lives.  Nearly three-quarters of consumers (72 percent) believe there is not much they can do about a cold except mask the symptoms and wait it out.  In fact, one-third of cold sufferers admit they wait until they feel miserable before taking medications that can help.

According to a second survey of U.S. pharmacists, this consumer belief is in direct contrast to what the majority of U.S. pharmacists believe – 93 percent of pharmacists report that early treatment of a cold can actually prevent a trip to the doctor's office, and 84 percent of pharmacists believe consumers often make poor choices about the best treatments for their colds.

The surveys, which were commissioned by Matrixx Initiatives, Inc., makers of Zicam, also found that most consumers harbor myths about what causes a cold and what remedies are effective.  While 86 percent of consumer survey respondents understand that colds are caused by viruses, 65 percent of consumer survey respondents also incorrectly believe that bacteria can cause a cold, and 53 percent of consumer survey respondents mistakenly believe you can treat a cold with antibiotics.  Consumers also tend to rely on a variety of home remedies, including chicken soup, orange juice and vitamins, even though nearly two-thirds (64 percent) of consumer survey respondents acknowledge that some of what they learned from their mothers about catching and treating colds is untrue and not based on science.

The top five myths about colds that pharmacists say are most difficult to debunk are:

  • Antibiotics can kill the germs that cause colds
  • Changes in the weather can cause colds
  • Getting wet and chilled can cause colds
  • Sitting in a draft can cause colds
  • Avoiding changes in temperatures will help prevent colds

As consumers prepare for cold season to hit, pharmacists say they see a need to better educate consumers and combat cold-care myths.  Ninety-two percent of pharmacists believe patients harbor misconceptions about colds and how to best treat and manage them, and 97 percent of pharmacists feel consumers should seek their recommendations about cold treatments and management more often.

"Consumer misperceptions about how they catch a cold – and how and when they should treat a cold – are the most prevalent barriers to optimal treatment," says Dr. Fred Eckel, professor of pharmacy practice and experiential education at the University of North Carolina Chapel Hill Eshelman School of Pharmacy.  "As cold season approaches, it's important for consumers to understand the benefits of early intervention against a cold, and to focus on effective ways to shorten its duration.  The results of this survey mirror what pharmacists see every day - our patients still believe many of the myths they grew up with and they need better information on how to treat their colds."

In addition to revealing consumer confusion about how and when to treat the common cold, the surveys also brought to light a discrepancy between consumers and pharmacists about when to prepare for a cold.  Ninety-one percent of pharmacists feel the appropriate time to assess and purchase over-the-counter medications is prior to becoming sick or at the first sign of symptoms, but only one in four (24 percent) consumers report having OTC cold and flu medications on hand for when they become sick.

According to the survey, most pharmacists typically recommend zinc, an active ingredient in Zicam, as an effective way to reduce the duration of a cold, but consumers have yet to catch up.  More than half (52 percent) of pharmacists typically recommend taking zinc products in the early stages of a cold, with only 12 percent of consumers proactively doing so.  In fact, the surveys show consumers are three times as likely to try chicken soup (41 percent) as a means of stopping the progression of a cold as they are to try zinc (12 percent).

"The surveys point to a clear need for pharmacists and doctors to educate consumers on early intervention, and help them identify the best remedies to treat the common cold early and help them get over it faster," says Dr. Eckel.  "Zinc-based products such as Zicam do more than just relieve symptoms - they are effective at actually shortening the duration of a cold."

As pharmacists continue to play a more prominent role in consumer care, 98 percent of pharmacists agree they should be more involved in educating consumers about appropriate cold treatments, and 83 percent of pharmacists believe they should be a primary resource of information about colds and flu.  Most consumers agree, with 89 percent of consumer survey respondents saying they feel comfortable asking pharmacists about OTC medicines and cold remedies.

About the Surveys

The consumer survey was based on a nationally representative sample of 500 U.S. adults.  Respondents were carefully sampled and recruited to represent the full U.S. adult population in terms of gender, age and region according to data from the U.S. Census Bureau.  Data was collected between August 17 and August 22, 2010.

The pharmacist survey was based on responses from a sample of 500 licensed pharmacists from independent, chain and large retail (supermarket) pharmacies.  The sample was drawn from a full list of more than 60,000 pharmacies in the United States.  Only one pharmacist per pharmacy was allowed to participate.  Data was collected between August 12 and August 25, 2010.  

The margin of sampling error for a purely random sample of 500 survey respondents is +/- 4 percentage points. Survey design, data collection and analysis were done by Versta Research and sponsored by Matrixx Initiatives, Inc.

About Zicam Cold Remedy

Most cold medicines are designed to mask cold symptoms; however, Zicam Cold Remedy is different. When taken at the first sign of a cold (within the first 24-48 hours), Zicam Cold Remedy products, which use propriety formulations of zinc gluconate and zinc acetate as the active ingredients, reduce the duration of a cold when used as directed. Two new Cold Remedy Plus items, Zicam Cold Remedy Plus RapidMelts® and Zicam Cold Remedy Plus Oral Mist™, which are specially formulated to deliver the product benefits of reducing the duration of a cold while also helping to provide symptom relief, are also available on retailer shelves this cold season.

About Matrixx Initiatives, Inc.

Matrixx Initiatives, Inc. is engaged in the development and marketing of over-the-counter health care products that utilize innovative drug delivery systems. Zicam, LLC, its wholly owned subsidiary, manufactures and markets a full line of Zicam brand pharmaceuticals, including two new products, Zicam Cold Remedy Plus RapidMelts® and Zicam Cold Remedy Plus Oral Mist™, as well as our existing products including Zicam Cold Remedy Plus Liqui-Loz™, Zicam Cold Remedy Zavors™, Zicam Cold Remedy Chewables, Zicam Cold Remedy Oral Mist™, Zicam Cold Remedy RapidMelts®, Zicam Allergy Relief™, Zicam Extreme Congestion Relief™, Zicam Sinus Relief™, as well as Zicam Cough products and Zicam Multi-Symptom relief items. For more information regarding Matrixx products, please visit www.Zicam.com.

Contacts:


Sarah Ingram

Sarah Sanders

GolinHarris

GolinHarris

213-438-8780

312-729-4414

[email protected]

[email protected]

SOURCE Matrixx Initiatives, Inc.

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.